MedTrace Logo

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

NCT02467634 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-06-02

No results posted yet for this study

Summary

A fellow eye controlled study of HUCNS-SC sub-retinal transplantation in subjects with bilateral GA AMD. All subjects will be assigned to HUCNS-SC transplantation.

Conditions

  • Age-Related Macular Degeneration

Interventions

BIOLOGICAL

HuCNS-SC sub-retinal transplantation

HuCNS-SC sub-retinal transplantation in subjects with bilateral GA AMD

Sponsors & Collaborators

  • StemCells, Inc.

    lead INDUSTRY

Principal Investigators

  • Joel Naor, MD · StemCells, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02467634 on ClinicalTrials.gov